Bruker Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Bruker de 2.5% y 6.7% por año respectivamente. Se prevé que el BPA crezca en un 3.8% al año. Se espera que la rentabilidad financiera sea de 25.3% en 3 años.
Información clave
2.5%
Tasa de crecimiento de los beneficios
3.8%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Life Sciences | 17.4% |
Tasa de crecimiento de los ingresos | 6.7% |
Rentabilidad financiera futura | 25.3% |
Cobertura de analistas | Good |
Última actualización | 22 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Bruker Corporation: An Aggressive Acquisition Strategy
Apr 24Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research
Apr 11Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)
Jan 22There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price
Jan 08Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?
Dec 26Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?
Nov 06Is Bruker (NASDAQ:BRKR) Using Too Much Debt?
Oct 23Here's Why Bruker (NASDAQ:BRKR) Has Caught The Eye Of Investors
Sep 25Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?
Aug 09Is Now The Time To Look At Buying Bruker Corporation (NASDAQ:BRKR)?
Jul 27Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet
Jul 11If EPS Growth Is Important To You, Bruker (NASDAQ:BRKR) Presents An Opportunity
Jun 26Is It Time To Consider Buying Bruker Corporation (NASDAQ:BRKR)?
Apr 25These 4 Measures Indicate That Bruker (NASDAQ:BRKR) Is Using Debt Reasonably Well
Apr 07Bruker (NASDAQ:BRKR) Ticks All The Boxes When It Comes To Earnings Growth
Feb 20Why Bruker Corporation (NASDAQ:BRKR) Could Be Worth Watching
Jan 17Is Bruker (NASDAQ:BRKR) Using Too Much Debt?
Dec 30Should You Think About Buying Bruker Corporation (NASDAQ:BRKR) Now?
Oct 16Here's Why We Think Bruker (NASDAQ:BRKR) Is Well Worth Watching
Oct 03Estimating The Intrinsic Value Of Bruker Corporation (NASDAQ:BRKR)
Sep 19Is Bruker (NASDAQ:BRKR) Using Too Much Debt?
Sep 05Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 3,687 | N/A | N/A | N/A | 4 |
12/31/2025 | 3,475 | 448 | 526 | 650 | 10 |
12/31/2024 | 3,263 | 338 | 470 | 581 | 9 |
12/31/2023 | 2,965 | 427 | 243 | 350 | N/A |
9/30/2023 | 2,818 | 319 | 206 | 316 | N/A |
6/30/2023 | 2,715 | 319 | 201 | 342 | N/A |
3/31/2023 | 2,621 | 312 | 149 | 284 | N/A |
12/31/2022 | 2,531 | 297 | 145 | 274 | N/A |
9/30/2022 | 2,506 | 275 | 119 | 242 | N/A |
6/30/2022 | 2,476 | 274 | 114 | 196 | N/A |
3/31/2022 | 2,458 | 282 | 176 | 262 | N/A |
12/31/2021 | 2,418 | 277 | 190 | 282 | N/A |
9/30/2021 | 2,362 | 270 | 254 | 347 | N/A |
6/30/2021 | 2,264 | 238 | 312 | 405 | N/A |
3/31/2021 | 2,118 | 204 | 304 | 395 | N/A |
12/31/2020 | 1,988 | 158 | 235 | 332 | N/A |
9/30/2020 | 1,960 | 158 | 169 | 265 | N/A |
6/30/2020 | 1,970 | 165 | 140 | 235 | N/A |
3/31/2020 | 2,035 | 177 | 141 | 234 | N/A |
12/31/2019 | 2,073 | 197 | 140 | 213 | N/A |
9/30/2019 | 2,026 | 207 | 144 | 210 | N/A |
6/30/2019 | 1,972 | 189 | 124 | 185 | N/A |
3/31/2019 | 1,925 | 184 | 159 | 210 | N/A |
12/31/2018 | 1,896 | 180 | 191 | 240 | N/A |
9/30/2018 | 1,873 | 98 | 170 | 211 | N/A |
6/30/2018 | 1,842 | 92 | 179 | 219 | N/A |
3/31/2018 | 1,813 | 84 | 125 | 166 | N/A |
12/31/2017 | 1,766 | 79 | 111 | 154 | N/A |
9/30/2017 | 1,706 | 151 | N/A | 142 | N/A |
6/30/2017 | 1,664 | 161 | N/A | 142 | N/A |
3/31/2017 | 1,621 | 152 | N/A | 177 | N/A |
12/31/2016 | 1,611 | 154 | N/A | 131 | N/A |
9/30/2016 | 1,619 | 146 | N/A | 190 | N/A |
6/30/2016 | 1,621 | 111 | N/A | 208 | N/A |
3/31/2016 | 1,646 | 119 | N/A | 188 | N/A |
12/31/2015 | 1,624 | 102 | N/A | 229 | N/A |
9/30/2015 | 1,654 | 66 | N/A | 149 | N/A |
6/30/2015 | 1,677 | 60 | N/A | 108 | N/A |
3/31/2015 | 1,739 | 55 | N/A | 123 | N/A |
12/31/2014 | 1,809 | 57 | N/A | 114 | N/A |
9/30/2014 | 1,853 | 66 | N/A | 176 | N/A |
6/30/2014 | 1,872 | 77 | N/A | 201 | N/A |
3/31/2014 | 1,870 | 83 | N/A | 182 | N/A |
12/31/2013 | 1,839 | 80 | N/A | 145 | N/A |
9/30/2013 | 1,805 | 58 | N/A | 105 | N/A |
6/30/2013 | 1,813 | 81 | N/A | 66 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (2.5% al año) de BRKR es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (2.5% al año) de BRKR crezcan menos que el mercado US (14.7% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de BRKR crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (6.7% al año) de BRKR crezcan más despacio que el mercado de US (8.1% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 6.7% al año) de BRKR crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de BRKR sea alta dentro de 3 años (25.3%)